$SQNM Up to date company activities and other impo
Post# of 94264
Posted On: 01/27/2014 11:27:21 AM
$SQNM Up to date company activities and other important information about $SQNM
$SQNM
DD Notes ~ http://www.ddnotesmaker.com/SQNM
##### recent news/filings ~ source: finance.yahoo.com
Fri, 17 Jan 2014 02:03:09 GMT ~ Sequenom's Management Presents at JPMorgan 32nd Annual Healthcare Conference (Transcript)
- We also market a series of other products in the prenatal arena, as well as macular degeneration. And in the area of prenatal testing, we’re one of the largest U.S. laboratories utilizing next-gen sequencing ...
read full: http://seekingalpha.com/article/1951081-seque...urce=yahoo
*********************************************************
Thu, 16 Jan 2014 23:12:56 GMT ~ Sequenom grants Nicox North American marketing rights for RetnaGene test
- Nicox and Sequenom announced an exclusive agreement in the age-related macular degeneration field. As part of this agreement, Nicox has been granted the North American promotional rights to the Sequenom ...
read full: http://finance.yahoo.com/news/sequenom-grants...56111.html
*********************************************************
Thu, 16 Jan 2014 22:59:00 GMT ~ Sequenom Laboratories grants Nicox exclusive promotion and marketing rights for its RetnaGene™ AMD test in North America
- SOPHIA ANTIPOLIS, France and SAN DIEGO, Jan. 16, 2014 /PRNewswire/ -- Nicox S.A. (NYSE Euronext Paris: COX), and Sequenom, Inc. (SQNM), today announced that their affiliate companies (Nicox Inc. and Sequenom Laboratories) have entered into an exclusive agreement in the age-related macular degeneration (AMD) field. As part of this agreement, Nicox has been granted the North American promotional rights to the Sequenom Laboratories RetnaGene™ AMD laboratory-developed test, for the evaluation of a patient's risk of AMD disease progression within 2, 5 and 10 years. The RetnaGene AMD test will be promoted by the same Nicox U.S. sales force which recently launched Sjo™, an advanced diagnostic panel for the early detection of Sjogren's Syndrome. Nicox expects to begin promoting the RetnaGene AMD test in the United States in the first half of 2014.
read full: http://finance.yahoo.com/news/sequenom-labora...00541.html
*********************************************************
Thu, 16 Jan 2014 07:28:08 GMT ~ Sequenom Laboratories grants Nicox exclusive promotion and marketing rights for its RetnaGene™ AMD test in North America
- PRESS RELEASE ………………………………………………………………………………………. Nicox further expands North American diagnostic portfolio with access to the RetnaGene AMD test, a genetic laboratory-developed test to predict the risk ...
read full: http://www.noodls.com/view/4C325AA2B6FA7FC7E5...B04F195CC0
*********************************************************
Tue, 14 Jan 2014 21:30:00 GMT ~ Sequenom Laboratories Expands Access to MaterniT21™ PLUS Test
- SAN DIEGO, Jan. 14, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, ...
read full: http://finance.yahoo.com/news/sequenom-labora...00383.html
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=SQNM&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=SQNM&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/SQNM/company-info
Ticker: $SQNM
OTC Market Place: Not Available
CIK code: 0001076481
Company name: Sequenom, Inc.
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/SQNM/filings
Latest financials: http://www.otcmarkets.com/stock/SQNM/financials
Latest news: http://www.otcmarkets.com/stock/SQNM/news - http://finance.yahoo.com/q/h?s=SQNM+Headlines
Major holdings: http://data.cnbc.com/quotes/SQNM/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=SQNM+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/SQNM.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=SQNM
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Sequenom%2C+Inc.&a...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...nom%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
http://www.pennystocktweets.com/stocks/profile/SQNM
##### last known share structure ~ source: otcmarkets.com
Market Value: $274,249,290 a/o Jan 24, 2014
Shares Outstanding: 115,717,000 a/o Oct 31, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
##### business description ~ source: otcmarkets.com
IC
DD Notes ~ http://www.ddnotesmaker.com/SQNM
$SQNM
DD Notes ~ http://www.ddnotesmaker.com/SQNM
##### recent news/filings ~ source: finance.yahoo.com
Fri, 17 Jan 2014 02:03:09 GMT ~ Sequenom's Management Presents at JPMorgan 32nd Annual Healthcare Conference (Transcript)
- We also market a series of other products in the prenatal arena, as well as macular degeneration. And in the area of prenatal testing, we’re one of the largest U.S. laboratories utilizing next-gen sequencing ...
read full: http://seekingalpha.com/article/1951081-seque...urce=yahoo
*********************************************************
Thu, 16 Jan 2014 23:12:56 GMT ~ Sequenom grants Nicox North American marketing rights for RetnaGene test
- Nicox and Sequenom announced an exclusive agreement in the age-related macular degeneration field. As part of this agreement, Nicox has been granted the North American promotional rights to the Sequenom ...
read full: http://finance.yahoo.com/news/sequenom-grants...56111.html
*********************************************************
Thu, 16 Jan 2014 22:59:00 GMT ~ Sequenom Laboratories grants Nicox exclusive promotion and marketing rights for its RetnaGene™ AMD test in North America
- SOPHIA ANTIPOLIS, France and SAN DIEGO, Jan. 16, 2014 /PRNewswire/ -- Nicox S.A. (NYSE Euronext Paris: COX), and Sequenom, Inc. (SQNM), today announced that their affiliate companies (Nicox Inc. and Sequenom Laboratories) have entered into an exclusive agreement in the age-related macular degeneration (AMD) field. As part of this agreement, Nicox has been granted the North American promotional rights to the Sequenom Laboratories RetnaGene™ AMD laboratory-developed test, for the evaluation of a patient's risk of AMD disease progression within 2, 5 and 10 years. The RetnaGene AMD test will be promoted by the same Nicox U.S. sales force which recently launched Sjo™, an advanced diagnostic panel for the early detection of Sjogren's Syndrome. Nicox expects to begin promoting the RetnaGene AMD test in the United States in the first half of 2014.
read full: http://finance.yahoo.com/news/sequenom-labora...00541.html
*********************************************************
Thu, 16 Jan 2014 07:28:08 GMT ~ Sequenom Laboratories grants Nicox exclusive promotion and marketing rights for its RetnaGene™ AMD test in North America
- PRESS RELEASE ………………………………………………………………………………………. Nicox further expands North American diagnostic portfolio with access to the RetnaGene AMD test, a genetic laboratory-developed test to predict the risk ...
read full: http://www.noodls.com/view/4C325AA2B6FA7FC7E5...B04F195CC0
*********************************************************
Tue, 14 Jan 2014 21:30:00 GMT ~ Sequenom Laboratories Expands Access to MaterniT21™ PLUS Test
- SAN DIEGO, Jan. 14, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, ...
read full: http://finance.yahoo.com/news/sequenom-labora...00383.html
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=SQNM&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=SQNM&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/SQNM/company-info
Ticker: $SQNM
OTC Market Place: Not Available
CIK code: 0001076481
Company name: Sequenom, Inc.
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/SQNM/filings
Latest financials: http://www.otcmarkets.com/stock/SQNM/financials
Latest news: http://www.otcmarkets.com/stock/SQNM/news - http://finance.yahoo.com/q/h?s=SQNM+Headlines
Major holdings: http://data.cnbc.com/quotes/SQNM/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=SQNM+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/SQNM.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=SQNM
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Sequenom%2C+Inc.&a...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...nom%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
http://www.pennystocktweets.com/stocks/profile/SQNM
##### last known share structure ~ source: otcmarkets.com
Market Value: $274,249,290 a/o Jan 24, 2014
Shares Outstanding: 115,717,000 a/o Oct 31, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
##### business description ~ source: otcmarkets.com
IC
DD Notes ~ http://www.ddnotesmaker.com/SQNM
(0)
(0)